$HZNP News Charting a bullish second-quarter backdrop

New Post Public Reply Private Reply Replies (1) Message Board
Stock_Tracker
$HZNP News

Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com

Trade-Ideas: Horizon Pharma (HZNP) Is Today's "Perilous Reversal" Stock 9:46 a.m. April 10, 2014 - TheStreet.com
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape 8:33 a.m. April 10, 2014 - Zacks.com
Best- And Worst-Performing Stocks YTD 10:13 a.m. April 2, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – XLRN MYGN HZNP WOOF 7:45 a.m. April 2, 2014 - InvestorPlace.com
Horizon Pharma's CEO Hosts Corporate Update Call 12:00 p.m. March 27, 2014 - Seeking Alpha
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:47 a.m. March 27, 2014 - Zacks.com
Horizon Pharma Inc Stock Downgraded (HZNP) 11:11 a.m. March 26, 2014 - TheStreet.com
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook 2:17 a.m. March 26, 2014 - Zacks.com
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews 2:17 a.m. March 26, 2014 - Zacks.com
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape 9:18 a.m. March 25, 2014 - Zacks.com
Roundtable Top Picks for the Week of Mar. 24th - Video Blog 4:52 p.m. March 24, 2014 - Zacks.com
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog 4:09 p.m. March 20, 2014 - Zacks.com
Horizon Pharma Has Significant Growth Potential 10:28 a.m. March 20, 2014 - Seeking Alpha
Horizon Pharma's CEO Discusses Acquisition of Vidara Therapeutics (Transcript) 4:14 p.m. March 19, 2014 - Seeking Alpha
Why Horizon Pharma (HZPN) Is Up Today 4:00 p.m. March 19, 2014 - TheStreet.com
Horizon Inks Reverse Merger With Vidara 10:30 a.m. March 19, 2014 - FOXBusiness
Horizon Pharma (HZNP) Hits New Lifetime High Today 9:45 a.m. March 19, 2014 - TheStreet.com
Horizon Pharma To Buy Vidara, Join Exodus To Ireland 9:45 a.m. March 19, 2014 - Investors Business Daily
Horizon Pharma to Acquire Vidara in $660 Million Deal 7:49 a.m. March 19, 2014 - The Wall Street Journal Interactive Edition
UPDATE: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash 6:13 a.m. March 19, 2014 - benzinga.com


Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 7:30 a.m. April 10, 2014 - Marketwire
Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma 9:59 a.m. April 2, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10:20 p.m. March 27, 2014 - Marketwire
Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 21st Annual Future Leaders in the Biotech Industry Conference 7:31 a.m. March 25, 2014 - Marketwire
Horizon Pharma to Host Corporate Update Meeting on March 27, 2014 7:30 a.m. March 24, 2014 - Marketwire
Horizon Pharma Inc. Acquires Vidara Therapeutics in a Reverse Merger Deal Worth $660M in Cash and Stock 12:30 a.m. March 20, 2014 - ACCESSWIRE
Deerfield Provides up to $250 Million in Acquisition Financing to Horizon Pharma 7:15 a.m. March 19, 2014 - BusinessWire - BZX
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc 7:01 a.m. March 19, 2014 - Marketwire
Market Major Trends - New High: Horizon Pharma, Norfolk Southern, Delphi Automotive, and Solazyme 5:40 a.m. March 14, 2014 - PR Newswire - PRF
Horizon Pharma Reports 2013 Financial Results and Provides Business Update 6:30 a.m. March 13, 2014 - Marketwire
Egalet Appoints Timothy P. Walbert to Board of Directors 8:14 a.m. March 11, 2014 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7:30 a.m. March 6, 2014 - Marketwire
Horizon Pharma to Present at the 26th Annual ROTH Conference 7:30 a.m. March 6, 2014 - Marketwire
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 3:30 p.m. March 5, 2014 - PR Newswire - PRF
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:30 a.m. March 5, 2014 - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:30 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:40 p.m. Feb. 11, 2014 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dahua's Pro Challenge 2026: Bridging Expertise Globally

Updated Category News Views 64

Celebrating Global Installer Expertise Dahua Technology took to the stage in Hangzhou for the Pro Challenge 2026, a shindig pulling installer partners from every corner of the globe. This wasn't just a tech jamboree; it was a tip of the hat to those on the ground who make Dahua's AIoT solutions tick. You know the drill: hands-on demos, tech showcases, and a whole lot of...

Continue Reading
Data Center Transformers on the Brink of a Boom

Updated Category News Views 235

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
Parallels Desktop: Top Dog for Windows on Mac

Updated Category News Views 75

A Simpler Way to Bridge the Mac and Windows World Seems like Parallels Desktop is once again flexing its muscles for Mac users in 2026. Expert Consumers out of New York just gave them the thumbs-up as the go-to pick for folks wanting to hitch their Mac wagon to Windows 11. And why not? Parallels lets you take a stroll through Windows land without cutting your Mac ties. A...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 46

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Greenworks Mower Snags Best Electric Award for 2026

Updated Category News Views 41

Greenworks Strikes Again with Top Lawn Mower Honors Man, when I think about the evolution from noisy, gas-guzzling lawn mowers to sleek, battery-powered beasts, Greenworks is right there, leading the charge. Just the other day, Popular Mechanics singled out the Greenworks 80V 22-inch Cordless Lawn Mower, handing it the coveted title of Best Electric Lawn Mower for 2026....

Continue Reading
ACME's AI Innovation Shakes Up Filmmaking Scene

Updated Category News Views 26

The Game-Changer in Virtual Production You ever hear about the Grey Box™ phenomenon? Sounds like a sci-fi gizmo, right? Turns out, it's the real deal and ACME Media's been riding this revolutionary wave straight to the top of the film industry ladder. Their approach with this AI-driven gizmo isn't just about cutting-edge tech wizardry—it's reimagining how we shoot...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Decoding Arrest: Steps from Arraignment to Trial

Updated Category News Views 71

Someone lands in handcuffs, and it's the start of a winding road through the justice system. We're talking about the stages you gotta navigate, explained by Criminal Law Attorney Tangi Carter. If you're anywhere near Hattiesburg, Mississippi, or quite frankly, have any eye on legal matters in your backyard, you know having a roadmap is pure gold. Arraignment: The...

Continue Reading
Millrose Faces Investor Deadline in Class Action Lawsuit

Updated Category News Views 75

Shakeup at Millrose Properties: Investor Alert! Alright, folks, gather around. We got a situation brewing with Millrose Properties, Inc. (NYSE: MRP) that's catching the attention of anyone who's hauled their portfolio through the storms and sunshine of the stock market. A class action lawsuit's knocking at the door, and any daydreaming investor who snatched up shares...

Continue Reading
AppLovin Faces Serious Investor Lawsuit Deadline

Updated Category News Views 72

Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Polymer Foam Market Trends and Insights for 2025-2034

Updated Category News Views 255

Understanding the Polymer Foam Market The polymer foam market has witnessed significant growth recently, with a valuation of USD 151.19 billion in 2024 and expectations of reaching USD 273.58 billion by 2034. This growth corresponds to a compound annual growth rate (CAGR) of 6.11% from 2025 to 2034. A substantial portion of this expansion is influenced by the increasing...

Continue Reading
Renee Gala Takes the Helm as Jazz Pharmaceuticals CEO

Updated Category News Views 249

Renee Gala Takes on Leadership at Jazz Pharmaceuticals In an exciting development for Jazz Pharmaceuticals, the Board of Directors has announced the unanimous selection of Renee Gala as the new President and Chief Executive Officer. This pivotal decision is set to take effect shortly, marking a significant transition for the company as it continues to forge its path in...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 58

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Fidelity National Financial Launches New Consent Solicitation

Updated Category News Views 304

Introduction to Consent Solicitation Fidelity National Financial, Inc. (NYSE: FNF) has recently announced the commencement of separate consent solicitations for its various series of Senior Notes, an initiative that aims to amend the terms of its existing indenture agreements. The company holds four series of Senior Notes—4.500% due in 2028, 3.400% due in 2030, 2.450%...

Continue Reading
Legal Insights on Hims & Hers Health, Inc. Class Action Case

Updated Category News Views 179

Understanding the Hims & Hers Health, Inc. Securities Litigation The legal landscape surrounding Hims & Hers Health, Inc. has become a focal point for investors as the recent securities fraud lawsuit unfolds. Investors have an opportunity to engage in this case, which may hold significant implications for their investments. Why This Lawsuit Matters This lawsuit,...

Continue Reading